QA: MYRIAD GENETICS INC in us_medicinal_products/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000899923_2021_MYRIAD_GENETICS_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.2817562452687358, 'aggregate_val': 846600000, 'exp_sum': 660500000, 'exp_to_value': {'GeneralAndAdministrativeExpense': 510100000, 'ResearchAndDevelopmentExpense': 77200000, 'remainder_Expenses': 73200000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000899923, MYRIAD GENETICS INC

  xvar xval
0 LiabilitiesNoncurrent 56,900,000
1 LiabilitiesCurrent 173,600,000
2 remainder_Liabilities 255,900,000
3 AssetsCurrent 331,700,000
4 AssetsNoncurrent 103,000,000
5 PropertyPlantAndEquipmentNet 37,000,000
6 Goodwill 932,900,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 510,100,000
9 ResearchAndDevelopmentExpense 77,200,000
10 remainder_Expenses 259,300,000
11 remainder_Revenues 638,600,000
12 remainder_NetIncome 8,400,000
13 remainder_ComprehensiveNetIncome 200,000
  yvar yval
0 Liabilities 486,400,000
1 Assets 1,404,600,000
2 Expenses 846,600,000
3 Revenues 638,600,000
4 StockholdersEquity 918,200,000
5 NetIncome -199,600,000
6 ComprehensiveNetIncome -199,500,000
7 BaseVar 1,692,400,000
8 EconomicCapitalRatio 0.614

Edgar->Model Mapping

Feature Distribution

Change over Time